Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US ...

Q4 2024 Earnings Call Transcript May 9, 2025 Christopher O’Reilly: Thank you very much for taking time out of their busy ...

Takeda Pharmaceuticals delivered strong FY2024 results and offers value with a 4.81% yield, despite pressure from Vyvanse ...

The announcement has sent share prices of pharmaceuticals companies around the world tumbling. Japanese companies Chugai ...

The U.S. president's social media post put pressure on drug-related stocks on worries their profits will take a hit if they ...

Takeda was scrambling to accommodate for rapidly sinking profits from the hasty decline of ADHD mainstay Vyvanse with a 140 ...

Kroger, Albertsons and others allege an unlawful monopoly in one legal case and aim to recover overcharges for a drug in ...

By Rachel Cohrs Zhang, Derek Wallbank, and Hadriana Lowenkron President Donald Trump said he plans to order a cut in US ...

His announcement is pressuring pharma stocks on worries their profits will take a hit if they have to cut prices in the US.

Takeda will host an investor call on Sunday ... but it is to illustrate that as a global innovative pharmaceutical company, we have a very strong presence in the U.S., which is, by far today ...